Christian Goess

Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.

S. C. Panchal, Philip B. Cox, P. Hajduk, 2020, Journal of medicinal chemistry.

NRF2 activator A-1396076 ameliorates inflammation in autoimmune disease models by inhibiting antigen dependent T cell activation

Christian Goess, P. Richardson, D. Donnelly-roberts, 2020, Journal of translational autoimmunity.

Fit-for-purpose LC-MS/MS quantification of leukotoxin and leukotoxin diol in mouse plasma without sample pre-concentration.

Christian Goess, D. B. Duignan, Gary J. Jenkins, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate.

Christian Goess, A. Hobson, S. Mathieu, 2022, Journal of medicinal chemistry.

POS0365 ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR ANTIBODY DRUG CONJUGATE FOR THE TREATMENT OF AUTOIMMUNE DISEASES

Christian Goess, S. Mathieu, M. Ruzek, 2021 .

The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity

Christian Goess, S. Mathieu, S. Rosenberg, 2009, The Journal of Immunology.

ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation

Christian Goess, S. Mathieu, E. Sampson, 2018, Modern rheumatology.